Understanding risky substance use among high school students
Interpretable Deep Forecasting of Hazardous Substance Use during High School
This study is looking at what leads some high school students to use harmful substances, so we can better understand and help those who might be at risk during this important time for their brain development.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10906941 on NIH RePORTER |
What this research studies
This research investigates the factors that contribute to hazardous substance use during high school, a critical period for brain development. By analyzing a wide range of data, including brain imaging and personal history, the study aims to identify both fixed and modifiable risk factors that predict substance use. The approach focuses on mapping individual characteristics to better understand how these factors interact and influence behavior. The goal is to develop a more accurate forecasting model that can help identify at-risk youth and inform prevention strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 12 to 20 who may be at risk for substance use due to various personal and environmental factors.
Not a fit: Patients who are outside the age range of 12 to 20 or who do not exhibit any risk factors for substance use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for predicting and preventing hazardous substance use among adolescents.
How similar studies have performed: Previous research has shown promise in using data-driven approaches to understand substance use behaviors, suggesting that this methodology could yield valuable insights.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Pohl, Kilian Maria — Stanford University
- Study coordinator: Pohl, Kilian Maria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.